trending Market Intelligence /marketintelligence/en/news-insights/trending/WHHmQi_YV0eHWHAvceznvg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

DexCom swings to profit in Q2, raises FY'19 guidance

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

DexCom swings to profit in Q2, raises FY'19 guidance

DexCom Inc. booked non-GAAP net income of $7.8 million, or 8 cents per share, for the second quarter of 2019, compared to a non-GAAP net loss of $6.5 million, or 7 cents per share, in the year-ago period.

The S&P Global Market Intelligence consensus normalized estimate for the quarter was one cent per share.

The San Diego, Calif.-based medical device maker's GAAP net loss was $10.5 million, or 12 cents per share, compared to GAAP net income of $30.2 million, or 34 cents per share, the year prior.

DexCom reported $336.4 million in revenue for the quarter, a 39% increase year-over-year from $242.5 million. U.S. revenue was up 40% while international revenue grew by 33%.

Research and development expenses were $69 million, up from $47.2 million a year ago.

DexCom increased its financial guidance for the full year of 2019 and now expects revenue in the range of approximately $1.33 billion to $1.38 billion, or 28% to 33% growth, compared to previous guidance of $1.25 billion to $1.30 billion, or 21% to 26% growth.